Organogenesis Holdings (ORGO) Operating Income Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) Operating Income Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | 21.25% |
| 10 | Organogenesis Holdings | 323.97 Mn | 231.87 Mn | 11.46 Mn | -157.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.57% |
| Dec 31, 2025 | 519.33% |
| Sep 30, 2025 | 232.06% |
| Jun 30, 2025 | 9.47% |
| Mar 31, 2025 | -594.34% |
| Dec 31, 2024 | 905.28% |
| Sep 30, 2024 | -22.46% |
| Jun 30, 2024 | -242.56% |
| Mar 31, 2024 | 3.72% |
| Dec 31, 2023 | -114.56% |
| Sep 30, 2023 | 352.50% |
| Jun 30, 2023 | -18.35% |
| Mar 31, 2023 | -3,025.78% |
| Dec 31, 2022 | -55.86% |
| Sep 30, 2022 | -89.06% |
| Jun 30, 2022 | -49.40% |
| Mar 31, 2022 | -101.01% |
| Dec 31, 2021 | -8.53% |
| Sep 30, 2021 | -28.67% |
| Jun 30, 2021 | 1,147.38% |